


SeQure DX Email Formats
Biotechnology Research • Waltham, Massachusetts, United States • 11-20 Employees
SeQure DX Email Formats
SeQure DX uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@maxcyte.com), used 88.9% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@maxcyte.com | 88.9% |
{first initial}{last name} | jdoe@maxcyte.com | 11.1% |
Key Contacts at SeQure DX
Sophia Oladimeji
Senior Director Program And Portfolio Management
Joe Mohr
Senior Director, Business Development
Company overview
| Headquarters | 1440 Main St, Suite 320, Waltham, MA 02451, US |
| Phone number | +19788281395 |
| Websites | |
| NAICS | 541714 |
| Keywords | Diagnostics, Regulatory Affairs, Genomics, Crispr, Gene Editing |
| Founded | 2021 |
| Employees | 11-20 |
| Socials |
About SeQure DX
SeQure DX™ is setting the standard for precision analytics in gene editing, delivering best-in-class off-target risk assessment services to advance safer, more effective cell and gene therapies. We provide a comprehensive suite of trusted assays—such as ONE-seq®, GUIDE-seq™, DEUX-seq™, Amplicon-seq™, Guide Profiler™, Guide Select™, and SAFER Detection™—that enable developers to detect, nominate, and confirm gene editing outcomes with high sensitivity and regulatory alignment. In January 2025, SeQure DX™ was acquired by MaxCyte, Inc., a leading cell engineering company, to form the core of MaxCyte’s Cell & Gene Therapy (CGT) Services business. Together, we provide an integrated solution that combines world-class cell engineering and comprehensive gene editing risk assessment services, helping therapeutic developers mitigate risk in their programs, accelerate timelines, and enable regulatory confidence from discovery through clinical stage and beyond.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
SeQure DX has 6 employees across 6 departments.
Departments
Number of employees
Frequently asked questions
4.8
40,000 users



